Instituto de Diagnóstico S.A.

SNSE:INDISA Stock Report

Market Cap: CL$224.2b

Instituto de Diagnóstico Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Instituto de Diagnóstico.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth27.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings

Dec 10
We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings

Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings

Jun 05
Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings

Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement

Sep 07
Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement

Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

Aug 17
Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)

May 19
A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)

Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

Apr 16
Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends

May 06
Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends

Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?

Mar 23
Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?

Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?

Mar 02
Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?

Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?

Feb 09
Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?

Jan 25
Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?

Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.

Jan 07
Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.

Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?

Dec 23
Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?

What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?

Dec 06
What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?

Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?

Nov 20
Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Instituto de Diagnóstico has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SNSE:INDISA - Analysts future estimates and past financials data (CLP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024235,3157,08022,10925,273N/A
6/30/2024230,6385,37317,88422,797N/A
3/31/2024225,6273,46020,79427,131N/A
12/31/2023218,93414412,30621,031N/A
9/30/2023208,743-1,75410,37323,598N/A
6/30/2023200,6536519,12025,711N/A
3/31/2023193,8264,6584,97125,776N/A
12/31/2022191,28813,050-2,35721,783N/A
9/30/2022191,91418,867-8,80219,627N/A
6/30/2022192,56821,805-20,85216,326N/A
3/31/2022190,22721,850-24,77212,686N/A
12/31/2021188,54320,650-19,07514,832N/A
9/30/2021181,91118,459-15,64414,702N/A
6/30/2021168,99114,035-2,56514,515N/A
3/31/2021149,2246,80412912,033N/A
12/31/2020139,3563,5011,23914,459N/A
9/30/2020132,9912,14025711,773N/A
6/30/2020136,8484,661-1,05510,415N/A
3/31/2020148,68710,3831,60812,541N/A
12/31/2019150,18511,6303,08910,661N/A
9/30/2019152,07412,0817,92511,885N/A
6/30/2019151,18012,6134,8119,223N/A
3/31/2019147,85914,8207,05811,443N/A
12/31/2018145,41114,6959,37514,755N/A
9/30/2018143,49214,8098,47018,058N/A
6/30/2018141,36714,435N/A24,238N/A
3/31/2018140,18812,115N/A14,988N/A
12/31/2017138,35111,888N/A14,891N/A
9/30/2017135,53311,850N/A7,087N/A
6/30/2017133,50211,803N/A10,455N/A
3/31/2017129,98511,646N/A12,805N/A
12/31/2016128,30812,934N/A11,570N/A
9/30/2016126,47814,209N/A18,074N/A
6/30/2016122,92214,049N/A13,454N/A
3/31/2016120,25013,816N/A15,478N/A
12/31/2015116,94213,132N/A15,054N/A
9/30/2015112,66611,958N/A14,003N/A
6/30/2015108,73211,545N/A14,364N/A
3/31/2015105,76311,332N/A13,254N/A
12/31/2014103,62811,730N/A13,582N/A
9/30/2014100,96711,673N/A12,790N/A
6/30/201498,04911,446N/A13,978N/A
3/31/201495,30711,138N/A14,569N/A
12/31/201392,29910,588N/A13,070N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if INDISA's forecast earnings growth is above the savings rate (5.5%).

Earnings vs Market: Insufficient data to determine if INDISA's earnings are forecast to grow faster than the CL market

High Growth Earnings: Insufficient data to determine if INDISA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if INDISA's revenue is forecast to grow faster than the CL market.

High Growth Revenue: Insufficient data to determine if INDISA's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if INDISA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 22:40
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Instituto de Diagnóstico S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steffania MosqueraCrediCorp Capital
Daniel Velandia OcampoCrediCorp Capital